Virax Biolabs Group Limited Gains 53.09%
Mon, May 18, 2026 at 06:58 PM
Virax Biolabs Group Limited (VRAX:NASDAQ) shot up at $0.24, representing a gain of 53.1%. On Mon, May 18, 2026, VRAX:NASDAQ hit a New 2-Week High of $0.24. From Mon, May 04, 2026, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Mon, May 18, 2026 at $0.53 with a volume of 760M+.
About Virax Biolabs Group Limited (VRAX:NASDAQ)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...
Top 10 Gainers:
- Wellgistics Health, Inc. (WGRX:NASDAQ), 108.38%
- Huachen AI Parking Management Technology Holding Co., Ltd (HCAI:NASDAQ), 98.56%
- AIM ImmunoTech Inc. (AIM:NYSEMKT), 61.26%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 53.09%
- NextNRG Inc. (NXXT:NASDAQ), 46.22%
- GCT Semiconductor Holding, Inc. (GCTS:NYSE), 40.98%
- Robo.ai Inc Cl B Ord (AIIO:NASDAQ), 39.3%
- Sachem Capital Corp. (SACH:NYSEMKT), 33.98%
- Smart for Life, Inc. (SMFL:NASDAQ), 33.33%
- TOP Financial Group Limited (TOP:NASDAQ), 30.66%